The firm said its next-generation siRNA candidate showed in preclinical studies that it could reduce tumor growth and metastatic spread.

The decision to expand the development plan follows recently reported promising preclinical findings demonstrating that ...

Silexion Therapeutics (SLXN) announced an expanded development plan for its next-generation siRNA candidate, SIL204. This strategy integrates ...

Optimizing gelatin hydrogels for volumetric 3D bioprinting. Insights from Rousselot’s Jos Olijve on the ENLIGHT bioprinting ...

Cancer advocates, researchers, clinicians and patients are speaking out in a new STAT News article published this week about the [...] READ MORE ...

OpenAI has integrated AI image generation directly into ChatGPT, powered by the GPT-4o model, allowing free and paid users to ...

Novel trispecific T cell engager, ZW209, demonstrates potent preclinical efficacy against DLL3-expressing tumors and an encouraging safety profile VANCOUVER, British Columbia, March 25, 2025 (GLOBE ...

A new model of brain metabolism – the most complex ever generated –shows how altering key chemicals could restore aged cells ...

More and more people are being diagnosed with pancreatic cancer. This disease is insidious, often only making itself known in ...

Despite weight loss and glycemic control, experts caution that type 2 diabetes remission is not a cure and that pancreatic ...

Long before mRNA vaccines captured global attention during the COVID-19 pandemic, researchers were already exploring their ...

Harvard Medical School professor Isaac Kohane remembers being asked, when he was a trainee doctor, to diagnose a child with ...